PureSkin

Critical solutions for burn management

The gold standard in burn care – Our cryopreserved allograft from AlloSource®

AlloSource® has helped save the lives of thousands of patients suffering from traumatic burns and helped restore mobility to countless others. A recognised global leader in the processing and distribution of skin allografts for burn management and wounds resulting from burn injuries, AlloSource® has become one of the largest suppliers of skin allografts used for these applications.

  • Minimal prep time – Ready-to-use
  • Consistent sizing and thickness – Easy to use and reliable quality
  • Flexible meshing options to suit – Non-meshed (meshed available on request)
  • Logistics – Same day and flexible options to help manage your time more effectively

For the out-of-hours service please call 01793 575 041.

We are licensed with the Human Tissue Authority (HTA) and recognise the importance of robust quality standards.

AlloSource requires a comprehensive donor physical assessment and a complete medical and social history to identify and eliminate donors that may be at risk of transmitting certain viruses and diseases. Our donor acceptance criteria are based on regulations established by the U.S. Food and Drug Administration (FDA), the American Association of Tissue Banks (AATB) Standards, as well as additional requirements set by the AlloSource Medical Advisory Board.

Donors must test negative or non-reactive in the following assays:

  • Antibody to Hepatitis C (HCV)
  • Antibody to Human Immunodeficiency Virus 1 & 2 (HIV 1 & 2)
  • Hepatitis B Core IgG/IgM Antibody (HBcAb)
  • Hepatitis B Surface Antigen (HBsAg)
  • Hepatitis C Virus (HCV NAT)
  • Human Immunodeficiency Virus Type 1 (HIV-1 NAT)
  • Rapid Plasma Reagin or Serologic Test for Syphilis (RPR or STS)

For the out-of-hours service please call 01793 575 041.

CONTACT US FOR INFORMATION
SKUs

5100-610
Allosource Split Thickness - 2:1
100-199cm²
Awaiting NHS SC codes from TOS3 framework
5100-612
Allosource Split Thickness - 2:1
200 cm² +
Awaiting NHS SC codes from TOS3 framework
5100-620
Allosource Split Thickness - 1:1
100-199cm²
Awaiting NHS SC codes from TOS3 framework
5100-622
Allosource Split Thickness - 1:1
200 cm² +
Awaiting NHS SC codes from TOS3 framework
5100-001
Allosource Split Thickness – Non-Meshed
100-199cm²
Awaiting NHS SC codes from TOS3 framework
5100-175
Allosource Split Thickness – Non-Meshed
200 cm² +
Awaiting NHS SC codes from TOS3 framework
5100- 624
Allsource Pure skin XL 2:1 meshed
600-999 cm²
Limited Supply
5100-626
Pureskin XL 2:1 meshed
>1000 cm²
Limited Supply
Clinical Studies

Author

Title

Emran S Sheikh, Ednan S Sheikh & Donald E Fetterolf

Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds

Alexis D. Armour, M.D., M.Sc. Joel S. Fish, M.D., M.Sc. Kimberly A. Woodhouse, P.Eng., Ph.D. John L. Semple, M.D., M.Sc.

A Comparison of Human and Porcine Acellularized Dermis: Interactions with Human Fibroblasts In Vitro

Chris Emerson, Fiona Bates, Stephen Lake, Michelle Mullan, Steve Pandey

Funding Arrangements for Use of Biological and Synthetic Mesh/Equivalents – February 2014

Sarkar A., *Rakshit P., Majumdar B.K., Bain J., Adhya A., Saha J.K., Dewangan Y.K.

Use of cadaveric skin allograft in management of deep burn wounds: our experience

Anh-Tuan N. Truong, MD, Areta Kowal-Vern, MD, Barbara A. Latenser, MD, Dorion E. Wiley, MD, and Robert J. Walter, PhD

Comparison of Dermal Substitutes in Wound Healing Utilizing a Nude Mouse Model

Diana Kitala, Marek Kawecki, Agnieszka Klama-Baryła1, Wojciech Łabuś, Małgorzata Kraut, Justyna Glik, Ireneusz Ryszkiel, Marek P. Kawecki, Mariusz Nowak

Allogeneic vs. Autologous Skin Grafts in the Therapy of Patients with Burn Injuries: A Restrospective, Open-label Clinical Study with Pair Matching

Dennis P. Orgill MD, PhD

Excision and Skin Grafting of Thermal Burns

AlloSource

Skin Evaluation Guide

AlloSource

Delivering critical treatment solutions for burn management

Skin grafting, Surgery Encyclopdia, 2016

I.S. Whitaker, S. Worthington, S. Jivan, A. Phipps

The use of Biobrane by burn units in the United Kingdom: A national study

Steven A. Kolenik III, MD & David J. Leffell, MD

The Use of Cryopreserved Human Skin Allografts in Wound Healing following

Juhasz, B. Kiss, L. Lukacs, I. Erdei, Z. Peter, and E. Remenyik

Long-Term Follow-up of Dermal Substitution with Acellular Dermal Implant in Burns and Postburn Scar Corrections

For any product information or to order, please get in touch

Get In Touch

Partner with us

Contact us

Careers